When discussing innovation in healthcare, the conversation often defaults to breakthrough technologies, accelerated R&D cycles, or the promise of AI. Yet as the industry looks toward 2030, a quieter but more decisive force is coming into focus: the people and cultures that determine whether innovation actually reaches patients. In early January, I had the opportunity to learn from Abigail Epane-Osuala, Chief Culture & Belonging Officer at GE HealthCare and President of the GE HealthCare Foundation, about the human capabilities that will define the next decade of MedTech, BioTech, and Pharma leadership and why culture is not a “soft” consideration, but a strategic operating system for healthcare’s future.

Abigail Epane-Osuala, Chief Culture & Belonging Officer, GE HealthCare

The Pulse: When we talk about preparing health care for 2030, innovation is often framed in terms of technology or science. From your vantage point, what people or cultural capabilities will most distinguish the MedTech, BioTech, and Pharma leaders who succeed over the next decade? How does your current role at GE HealthCare and your prior experiences at Johnson & Johnson and Integra LifeSciences shape your perspective? 

Abigail Epane-Osuala: As healthcare moves toward 2030, sustained success will be shaped by the human capabilities organizations build around technology. Innovation increasingly depends on how people make decisions under pressure, collaborate across disciplines, and take responsibility for outcomes that affect patients and clinicians. Cultures that emphasize clarity, accountability, and trust enable teams to move faster with confidence, adapt when assumptions change, and maintain credibility with customers and regulators. These cultural conditions allow innovation to progress in complex environments without breaking down execution or values.

From a people perspective, three capabilities stand out. First is learning agility: the ability for teams to continuously adapt as science, data, and care models evolve. Second is cross-disciplinary collaboration, where clinicians, technologists, scientists, and operators work together with shared accountability. Third is ethical judgment at scale, especially as decisions become more data-driven and less linear.

Across my roles at GE HealthCare, Johnson & Johnson, and Integra LifeSciences, I have seen how leadership behaviors directly influence outcomes during moments of uncertainty. In periods of transformation, the teams that performed best were led by individuals who were clear about priorities, consistent in their values, and open to input from across the organization. When leaders created space for candid discussion and shared ownership of decisions, teams were better able to manage risk, learn quickly, and stay aligned to patient impact. Those experiences reinforced for me that culture functions as an operating system, shaping how work actually gets done when timelines compress and stakes are high.

The Pulse: Health care innovation cycles are becoming faster, riskier, and more interdisciplinary. How is GE HealthCare intentionally designing culture and leadership behaviors to help teams thrive amid sustained uncertainty?

AE: GE HealthCare has a long history of innovating in environments where stakes are high and complexity is real. That legacy shapes how we think about culture today. Innovation here has never been about moving fast for its own sake. It has been about moving with discipline, responsibility, and respect for the people who rely on our technologies every day.

From a cultural standpoint, we place a premium on leaders being deeply connected to the work and the people doing it. Decisions are expected to be grounded in what is actually happening in clinical and operational settings. That closeness enables leaders to spot risks earlier, make course corrections sooner, and support teams as they navigate uncertainty. It also reinforces accountability, because ownership is clear and shared.

As innovation cycles accelerate, we rely on a lean, problem-solving mindset that has been part of GE HealthCare for decades. Teams are encouraged to simplify complexity, learn through action, and continuously improve rather than wait for perfect answers. A founder’s mentality reinforces this approach, creating a sense of personal responsibility for outcomes and a bias toward practical solutions. From a belonging perspective, this matters because people do their best work when expectations are clear, contributions are valued, and learning is treated as part of progress. That combination allows GE HealthCare to extend its legacy of innovation while adapting to the realities of a rapidly changing healthcare landscape.

The Pulse: Looking toward 2030, what talent strategies do you believe will become true competitive advantages for MedTech, BioTech, and Pharma companies, particularly as competition for digital, AI, and scientific talent intensifies?

Abigail Epane-Osuala: By 2030, the advantage will shift from simply attracting talent to sustaining environments where diverse talent can grow and stay. Organizations that rely on transactional talent strategies will struggle in a market where skills evolve faster than roles.

I believe the strongest strategies will focus on three areas. First is continuous capability building, where learning is embedded into daily work. Second is internal mobility, enabling people to move across functions and disciplines as the business evolves. Third is a clear and credible employee value proposition that connects purpose, development, and well-being.

At GE HealthCare, our focus on belonging plays a central role in this. When people feel seen, trusted, and connected to meaningful work, they are more likely to contribute their best ideas and stay engaged over time. That continuity matters in industries where long-term impact depends on collective expertise.

The Pulse: How do you think the definition of ‘effective leadership’ in healthcare will change by 2030, and what are organizations under-investing in today when it comes to developing those leaders?

AE: Effective leadership in healthcare already extends well beyond technical expertise or operational excellence. Today’s leaders are expected to navigate complexity with judgment, make principled decisions when conditions are uncertain, and lead teams that are increasingly diverse, distributed, and interdisciplinary. These expectations are no longer emerging; they are foundational to leading in healthcare now.

What many organizations continue to under-invest in is the human side of leadership development. Skills such as listening, inclusive decision-making, coaching through change, and managing energy during sustained pressure directly influence trust, engagement, and ethical judgment. These capabilities shape how teams perform when the work is complex and the stakes are high.

Leadership development also needs to begin earlier and be grounded in real experience. Waiting until someone reaches a senior role to focus on how they lead people is often too late. Developing effective healthcare leaders requires intentional investment in how leaders show up every day, not just how they deliver results.

The Pulse: As organizations scale new technologies like AI and precision medicine, how can leaders ensure that speed and scale don’t come at the expense of trust, ethics, and human connection?

AE: Speed and scale place real demands on organizations, which makes leadership intent even more important. Trust and ethics must be reinforced through governance, behaviors, and accountability.

Leaders play a critical role by setting clear expectations around responsible innovation, responsible AI use, data stewardship, and transparency. That includes involving diverse perspectives in decision-making and creating mechanisms for questions or concerns to be raised without fear.

Equally important is maintaining human connection. Technology should support clinicians, patients, and teams rather than distance them. Leaders who consistently link innovation back to its human impact help ensure that progress remains grounded in empathy and purpose.

The Pulse: If you had to place one bold bet on what will matter most for building innovative, resilient health care organizations by 2030 (something that’s under-appreciated today) what would it be?

AE: My bold bet would be on belonging as a strategic capability. It is often discussed in cultural terms, but its impact on resilience, innovation, and ethical decision-making is still under-appreciated.

Organizations that intentionally build environments where people feel valued, included, and accountable to one another are better equipped to handle disruption. Belonging strengthens trust, encourages candor, and enables faster learning. Those qualities become essential as healthcare organizations navigate complexity at scale.

By 2030, I believe the most innovative healthcare organizations will be those that treat belonging as foundational to business performance.

The Pulse: The message is clear: The future of healthcare in 2030 will largely be shaped by talent and people; without them, even the most advanced technologies fall short. By intentionally empowering talent and fostering a genuine sense of belonging, organizations can build cultures and leaders to last long-term.